2nd Department of Internal Medicine Cardiology and Angiology General University Hospital and 1st Faculty of Medicine of Charles University Prague Czech Republic

College of Medicine and Health Sciences United Arab Emirates University Al Ain United Arab Emirates

Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan

Department of Health Promotion Mother and Child Care Internal Medicine and Medical Specialties G D'Alessandro University of Palermo Palermo Italy

Department of Nephrology Institute of Nephrology Ruijin Hospital The Medical School of Shanghai Jiao Tong University Shanghai China

Division of Medical Genetics University of Versailles Montigny France

Division of Nephrology Department of Medicine Dalhousie University Halifax NS Canada

Emory University School of Medicine Atlanta GA USA

Fabry International Network Greece

Gazi University Faculty of Medicine Ankara Türkiye

Genetic Unit Pediatric Department Qatif Central Hospital Qatif Saudi Arabia

Hebrew University Hadassah School of Medicine Shaare Zedek Medical Center Jerusalem Israel

Institute of Clinical Medicine National Yang Ming University Taipei Taiwan; Department of Pediatrics Taipei Veterans General Hospital Taipei Taiwan

Multigen Genetic Diseases Diagnosis Center Izmir Türkiye

Neurology Department SPINE FUNDATION Buenos Aires Argentina

Neurology Unit St Bassiano Hospital Bassano del Grappa Italy

Reference Center of Lysosomal Storage Disorders Hospital Senhora da Oliveira Guimaraes Portugal

Referral Center for Fabry Disease and Lysosomal Diseases MetabERN APHP University Paris Saclay Garches France

Referrence Centre for Fabry Disease AOUP P Giaccone University Hospital Palermo Italy

Sanofi Cambridge MA

Service of Nephrology Department of Internal Medicine Federal University of Paraná Curitiba Brazil

Taipei Veterans General Hospital and National Yang Ming Chiao Tung University Taipei Taiwan

Tareev Clinic of Internal Diseases Sechenov 1st Moscow State Medical University Moscow Russia

The University of Western Australia Perth Australia; Genetic Health WA King Edward Memorial Hospital Perth Australia

University Hospitals Queen Elizabeth Institute of Cardiovascular Sciences University of Birmingham Birmingham United Kingdom

University Institute of Health Sciences H A Barceló Foundation Buenos Aires Argentina

Zobrazit více v PubMed

Germain D.P. Fabry disease. Orphanet J Rare Dis. 2010;5:30. doi: 10.1186/1750-1172-5-30. PubMed DOI PMC

Germain D.P., Moiseev S., Suárez-Obando F., et al. The benefits and challenges of family genetic testing in rare genetic diseases-lessons from Fabry disease. Mol Genet Genomic Med. 2021;9(5) doi: 10.1002/mgg3.1666. PubMed DOI PMC

Wang R.Y., Lelis A., Mirocha J., Wilcox W.R. Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med. 2007;9(1):34–45. doi: 10.1097/GIM.0b013e31802d8321. PubMed DOI

Ortiz A., Germain D.P., Desnick R.J., et al. Fabry disease revisited: management and treatment recommendations for adult patients. Mol Genet Metab. 2018;123(4):416–427. doi: 10.1016/j.ymgme.2018.02.014. PubMed DOI

Echevarria L., Benistan K., Toussaint A., et al. X-chromosome inactivation in female patients with Fabry disease. Clin Genet. 2016;89(1):44–54. doi: 10.1111/cge.12613. PubMed DOI

Moreno-Martinez D., Aguiar P., Auray-Blais C., et al. Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus. Mol Genet Metab. 2021;132(4):234–243. doi: 10.1016/j.ymgme.2021.02.001. PubMed DOI

Gragnaniello V., Burlina A.P., Polo G., et al. Newborn screening for Fabry disease in Northeastern Italy: results of five years of experience. Biomolecules. 2021;11(7):951. doi: 10.3390/biom11070951. PubMed DOI PMC

Chien Y.H., Hwu W.L., Lee N.C. Newborn screening: Taiwanese experience. Ann Transl Med. 2019;7(13):281. doi: 10.21037/atm.2019.05.47. PubMed DOI PMC

Sawada T., Kido J., Sugawara K., et al. Detection of novel Fabry disease-associated pathogenic variants in Japanese patients by newborn and high-risk screening. Mol Genet Genomic Med. 2020;8(11) doi: 10.1002/mgg3.1502. PubMed DOI PMC

Yoshida S., Kido J., Sawada T., et al. Fabry disease screening in high-risk populations in Japan: a nationwide study. Orphanet J Rare Dis. 2020;15(1):220. doi: 10.1186/s13023-020-01494-6. PubMed DOI PMC

Sawada T., Kido J., Tsukimura T., et al. Evaluation of GLA variants detected in newborn screening for Fabry disease using biomarker analysis. Mol Genet Metab Rep. 2025;44 doi: 10.1016/j.ymgmr.2025.101245. PubMed DOI PMC

Azevedo O., Gal A., Faria R., et al. Founder effect of Fabry disease due to p.F113L mutation: clinical profile of a late-onset phenotype. Mol Genet Metab. 2020;129(2):150–160. doi: 10.1016/j.ymgme.2019.07.012. PubMed DOI

Kirkilionis A.J., Riddell D.C., Spence M.W., Fenwick R.G. Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an NcoI polymorphism detected by an alpha-galactosidase cDNA clone. J Med Genet. 1991;28(4):232–240. doi: 10.1136/jmg.28.4.232. PubMed DOI PMC

West M.L., Dyack S., Riddell C., Lemoine K., Camfield C.S., Camfield P.R. A Nova Scotia kindred with Fabry disease. Acta Paediatr. 2002;91(s439):116. doi: 10.1111/j.1651-2227.2002.tb03123.x. 116. DOI

Germain D.P., Jurca-Simina I.E. In: Neurometabolic Hereditary Diseases of Adults. Burlina A.P., editor. Springer International Publishing; 2018. Principles of human genetics and Mendelian inheritance; pp. 1–28. DOI

Germain D.P., Al Murshedi F., Al Jasmi F., et al. Facilitating intrafamily communication to enable earlier diagnosis of Fabry disease in relatives: expert opinion. Mol Genet Metab. 2024;141(2) doi: 10.1016/j.ymgme.2023.107838. DOI

Körver S., Geurtsen G.J., Hollak C.E.M., et al. Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and pain. Orphanet J Rare Dis. 2020;15(1):28. doi: 10.1186/s13023-020-1307-y. PubMed DOI PMC

Munro M., Cook A.M., Bogart K.R. An inductive qualitative content analysis of stigma experienced by people with rare diseases. Psychol Health. 2022;37(8):948–963. doi: 10.1080/08870446.2021.1912344. PubMed DOI

Bogart K.R. Disability is a social identity. It’s time for therapy to affirm it. Dev Med Child Neurol. 2023;65(3):300–301. doi: 10.1111/dmcn.15412. PubMed DOI

Biddell C.B., Waters A.R., Angove R.S.M., et al. Facing financial barriers to healthcare: patient-informed adaptation of a conceptual framework for adults with a history of cancer. Front Psychol. 2023;14 doi: 10.3389/fpsyg.2023.1178517. PubMed DOI PMC

Downes M.J., Mervin M.C., Byrnes J.M., Scuffham P.A. Telephone consultations for general practice: a systematic review. Syst Rev. 2017;6(1):128. doi: 10.1186/s13643-017-0529-0. PubMed DOI PMC

Germain D.P., Gruson D., Malcles M., Garcelon N. Applying artificial intelligence to rare diseases: a literature review highlighting lessons from Fabry disease. Orphanet J Rare Dis. 2025;20(1):186. doi: 10.1186/s13023-025-03655-x. PubMed DOI PMC

Drossman D.A. 2012 David Sun lecture: helping your patient by helping yourself—how to improve the patient-physician relationship by optimizing communication skills. Am J Gastroenterol. 2013;108(4):521–528. PubMed